Article Information
History
- June 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kristin L. Andrejko, PhD1,2,†,*,
- Jake Pry, PhD2,*,
- Jennifer F. Myers, MPH2,
- Megha Mehrotra, PhD2,
- Katherine Lamba, MPH2,
- Esther Lim, MPH2,
- Nozomi Fukui, BS2,
- Jennifer L. DeGuzman, MPH2,
- John Openshaw, MD2,
- James Watt, MD, MPH2,
- Seema Jain, MD2,†,
- Joseph A. Lewnard, PhD1,3,4 and
- the California COVID-19 Case-Control Study Team§
- 1Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California, United States
- 2California Department of Public Health, Richmond, California, United States
- 3Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, California, United States
- 4Center for Computational Biology, College of Engineering, University of California, Berkeley, California, United States
- ↵†Joint corresponding authors: Seema Jain, MD, 850 Marina Bay Parkway, Richmond, California 94804, United States, Tel.: +1 (510)-620-3444, E-mail: Seema.Jain{at}cdph.ca.gov, Kristin Andrejko, PhD, 850 Marina Bay Parkway, Richmond, California 94804, United States, Tel.: +1 (510)-620-3444, E-mail: Kristin.Andrejko{at}cdph.ca.gov
↵* KA and JP contributed equally to the study.